AZD5991
Axon 3731
CAS:
2143061-81-6
- Optical Purity: 99% e.e.
- Soluble in DMSO
- MF: C35H36ClN5O3S2
- MW: 674.28
Description
AZD5991 is a potent and selective BH3-groove-binding Mcl-1 inhibitor with sub-nanomolar affinity for the target. It demonstrates all the hallmarks of a true Mcl-1 inhibitor: 1. potent, selective, and rapid apoptosis in Mcl-1-dependent cell lines (e.g., GI50 as low as 10 nM in multiple myeloma cell lines); 2. loss of activity upon overexpression of Bcl-xL or siRNA-mediated knockout of Bak; 3. Mcl-1:Bak complex disruption as demonstrated by co-immunoprecipitation. AZD5991 is active in vivo, with complete (100%) tumor regression demonstrated in several mouse xenograft models after a single tolerated dose.
More Information
| Parent CAS No. | 2143061-81-6 |
|---|---|
| Chemical Name | 17-Chloro-5,13,14,22-tetramethyl-28-oxa-2,9-dithia-5,6,12,13,22-pentazaheptacyclo[27.7.1.14,7.011,15.016,21.020,24.030,35]octatriaconta-1(36),4(38),6,11,14,16,18,20,23,29(37),30,32,34-tridecaene-23-carboxylic acid |
| extra_info | Sold in collaboration with Chemietek |
| SMILES | C1=CC2C3CCCOC4C=C(SCC5N(C)N=C(C=5)CSCC5=NN(C)C(C)=C5C(C=2N(C)C=3C(O)=O)=C1Cl)C=C1C=CC=CC=41 |
| MFCD | N.A. |
| InChi | InChI=1S/C35H34ClN5O3S2/c1-20-31-29(38-40(20)3)19-45-17-22-15-23(41(4)37-22)18-46-24-14-21-8-5-6-9-25(21)30(16-24)44-13-7-10-26-27-11-12-28(36)32(31)33(27)39(2)34(26)35(42)43/h5-6,8-9,11-12,14-16H,7,10,13,17-19H2,1-4H3,(H,42,43) |
| InChiKey | KBQCEQAXHPIRTF-UHFFFAOYSA-N |
| CID | 131634760 |
| Short Description | BH3-Groove binding Mcl-1 inhibitor |
References
- AW Hird, et al. Proceedings: AACR Annual Meeting 2017; April 1-5, 2017; Washington, DC AZD5991: A potent and selective macrocyclic inhibitor of Mcl-1 for treatment of hematologic cancers, AACR; Cancer Res 2017, 77:Abstract nr DDT01-02.
- AE Tron et al. Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute myeloid leukemia. Nat Commun. 2018, 9(1), 5341.
Other Categories
Get a Quote for
Loading...